Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

Frontiers In Digital Health

by Cindy H. Lee, Yang Zhang, Barbara J. McClure, Angelina Yong, Hamish S. Scott, Chung Hoow Kok
March 18, 2026

Frontiers In Cardiovascular Medicine

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

by Rui Zhang, Yue Weng, Shuting Wu, Ting Liao, Ping Pan, Hongmei Gou, Wei Ding, Mingjiang Dong, Zhongwen Yang
April 24, 2026

The Medicine Maker

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

May 12, 2026
7 min

Frontiers In Oncology

Differential expression of immune activation markers in T cells from patients with multiple myeloma

by Jiaoya Lin, Xin Zhang, Yifei Zhao, Lan Luo, Hong Yuan, Ling Zhong
May 20, 2026

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

Original Source(s)

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

Related Content

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

Differential expression of immune activation markers in T cells from patients with multiple myeloma